Latest News

Verrica Pharmaceuticals (VRCA) just closed out FY 2025 with Q4 revenue of US$5.1 million and a basic EPS loss of US$0.57, alongside trailing 12 month revenue of US$35.6 million and a basic EPS loss of US$1.68. Over the past few quarters, the company has seen revenue move from US$3.4 million in Q1 2025 to US$12.7 million in Q2 and US$14.3 million in Q3, while quarterly basic EPS has ranged from a loss of US$1.03 in Q1 to a small profit of US$0.02 in Q2 and a near breakeven loss of US$0.03 in...

MongoDB (MDB) has just wrapped up FY 2026 with Q4 revenue of US$695.1 million and basic EPS of US$0.19, alongside trailing 12 month revenue of US$2.5 billion and a trailing basic EPS loss of US$0.88. Over recent quarters the company has seen revenue move from US$549.0 million in Q1 FY 2026 to US$695.1 million in Q4, while quarterly basic EPS has ranged from a loss of US$0.58 in Q2 to a profit of US$0.19 in Q4. This sets up a results season where investors are likely to focus on how improving...

If you are wondering whether Heidelberg Materials at around €162.65 is offering good value or asking too much, you are not alone. The share price has seen a 9.7% decline over the last 7 days and a 24.8% decline over the last 30 days, sitting 26.7% lower year to date after a very large 3 year return and a 163.0% return over 5 years. Recent coverage has focused on how cement and construction materials producers like Heidelberg Materials are positioned as interest rates, construction activity,...

Klöckner & Co (XTRA:KCO) closed out FY 2025 with Q4 revenue of €1,462 million and a basic EPS loss of €0.14, while trailing 12 month figures show €6.38 billion of revenue and a basic EPS loss of €0.54, keeping the company in loss making territory. Over recent quarters, revenue has moved from €1,666.30 million in Q1 2025 to €1,642.80 million in Q2, €1,609.44 million in Q3 and €1,462 million in Q4, with EPS shifting from a loss of €0.28 in Q1 to a small profit of €0.02 in Q2, then back to...

Pharming Group (ENXTAM:PHARM) has wrapped up FY 2025 with fourth quarter revenue of US$106.5 million and basic EPS of US$0.008, while trailing twelve month figures stand at US$376.1 million in revenue and basic EPS of US$0.004. This frames a year where profitability on a full year basis edges into positive territory. The company has seen quarterly revenue move from US$92.7 million in Q4 2024 and US$74.8 million in Q3 2024 to US$106.5 million in Q4 2025. Over the same period, quarterly basic...

Geberit (SWX:GEBN) has wrapped up FY 2025 with fourth quarter revenue of CHF 715.4 million and Basic EPS of CHF 3.14, alongside trailing twelve month revenue of CHF 3.2 billion and EPS of CHF 18.15 that frame the full year earnings picture. Over recent periods, the company has seen quarterly revenue move from CHF 685.3 million in Q4 2024 to CHF 715.4 million in Q4 2025, while Basic EPS in those fourth quarters shifted from about CHF 2.93 to CHF 3.14. This gives investors a clear read on top...

Sunrise Realty Trust (SUNS) has just wrapped up FY 2025 with fourth quarter revenue of US$3.6 million and basic EPS of US$0.12, alongside trailing twelve month EPS of US$0.93 on revenue of US$19.5 million and year over year earnings growth of 73.2%. Over the past year, the company has seen quarterly revenue range from US$3.6 million to US$6.3 million, with basic EPS moving between US$0.12 and US$0.30. Trailing twelve month figures indicate that analysts are currently forecasting earnings...

SYS-DAT (BIT:SYS) has just wrapped up FY 2025 with fourth quarter revenue of €24.3 million and net income of €2.0 million, while the trailing 12 month figures sit at €89.6 million of revenue and €6.9 million of net income. The company has seen quarterly revenue move from €16.2 million in Q4 2024 to €24.3 million in Q4 2025, with trailing 12 month net income ranging between €6.2 million and €7.4 million over the past six reported quarters. This sets up a story that comes down to how...

Chocoladefabriken Lindt & Sprüngli (SWX:LISN) has wrapped up FY 2025 with second half revenue of CHF3.6b and basic EPS of CHF2,368.83, alongside net income of CHF538.3m, setting the tone for how investors will read the latest full year story. Over the past few periods, the company has seen revenue move from CHF3.3b in 2H 2024 to CHF3.6b in 2H 2025, while trailing twelve month basic EPS tracked at CHF3,163.95 and net income at CHF727.2m. This gives a clearer view of the earnings run rate...

Blue Owl Capital (NYSE:OWL) and Blackstone have agreed to acquire a minority stake in Atlas Holdings, expanding their exposure to private equity ownership. Separately, Glendon Capital has publicly criticized Blue Owl's private credit valuation transparency, raising questions about potential understated losses in parts of its portfolio. For you as an investor, these two developments pull NYSE:OWL in different directions at the same time. On one side, the Atlas Holdings deal broadens Blue Owl...

Why Axogen Is Back on Investors’ Radar Axogen (AXGN) has re-entered the spotlight after executives detailed accelerating commercial momentum, a cleaner balance sheet following recent capital raising and debt repayment, and the December BLA approval for its AVANCE nerve graft. See our latest analysis for Axogen. Axogen’s share price has moved around recent news, with a 7 day share price return of 8.92% and a 1 day decline of 1.64%. Its 1 year total shareholder return of 85.08% and 3 year total...

RWE (XTRA:RWE) has just wrapped up FY 2025 with fourth quarter revenue of €9.3b and basic EPS of €1.26, alongside net income of €831m, putting concrete numbers around its recent trading price of €55.60. Over the last few quarters, the company has seen revenue range from €3.2b to €9.3b and quarterly EPS move between €0.91 and €1.26 in 2025. This sits against a trailing twelve month EPS of €4.30 and net income of €3.1b, which sets the scene for how you might think about its 10% net margin and...

Franco-Nevada (TSX:FNV) agreed to a A$220 million royalty funding package with Minerals 260 Ltd. for the Bullabulling gold project in Australia. The Bullabulling agreement is the company’s largest royalty commitment in Australia to date and expands its effective royalty rate and land package exposure. Franco-Nevada, a precious metals and royalties company, is adding Bullabulling to its portfolio at a time when many miners are seeking alternative financing for large projects. For you as an...

Chicago Atlantic Real Estate Finance (REFI) has wrapped up FY 2025 with fourth quarter total revenue of US$14.1 million and basic EPS of US$0.39, giving investors fresh numbers to weigh against its high headline yield and recent margin trends. The company has seen quarterly revenue move between US$13.1 million and US$15.4 million over the last six reported periods, while basic EPS ranged from US$0.39 to US$0.57 over the same timeframe. This sets a clear frame of reference for the latest print...

K+S (XTRA:SDF) has wrapped up FY 2025 with Q4 revenue of €932.9 million and EPS of €3.19, putting a spotlight on how its top and bottom lines are moving after a volatile year. The company has seen quarterly revenue move between €866.2 million and €964.7 million across the last six reported periods, while EPS has swung from a loss of €9.68 per share in Q2 2025 to a small loss of €0.15 per share in Q3 2024 and then €3.19 per share in Q4 2025. This sets up an earnings story that is focused on...

DNB Bank (OB:DNB) has just posted its FY 2025 numbers, with Q4 revenue at NOK 22.7b and EPS of NOK 7.55 setting the tone for the full year. Over the last few quarters, revenue has ranged from NOK 21.5b to NOK 22.7b, while quarterly EPS moved between NOK 6.81 and NOK 8.14. This gives you a clear view of how the top line and EPS have tracked together into the latest print. With trailing net profit margins easing from 51.4% to 47.6%, this set of results puts the focus firmly on how sustainable...

LifeMD (LFMD) is back in focus after its latest earnings, where the telehealth provider reported full year 2025 net income of US$14.35 million and issued fresh 2026 revenue guidance. See our latest analysis for LifeMD. LifeMD’s latest earnings and 2026 guidance have arrived after a sharp recent move, with a 7 day share price return of 31.17% and a 30 day share price return of 29.02% despite a 1 year total shareholder return decline of 30.48%. Short term momentum is building, while the longer...

Kardex Holding (SWX:KARN) has just posted its FY 2025 numbers with first half revenue of €415.7 million, basic EPS of €4.69 and net income of €36.2 million, while the trailing twelve months show revenue of €850.4 million, EPS of €5.39 and net income of €41.6 million. The company has seen revenue move from €369.7 million and EPS of €4.95 in 2024 H1 to €421.5 million and EPS of €5.50 in 2024 H2, setting up FY 2025 results against a backdrop of shifting profitability and mixed margin signals...

Huber+Suhner (SWX:HUBN) has just posted its FY 2025 first half results, logging revenue of CHF 445.9 million and basic EPS of CHF 1.97, compared with revenue of CHF 430.6 million and EPS of CHF 1.87 in the first half of FY 2024. Over the same period, trailing twelve month revenue has been in the range of CHF 864.1 million to CHF 909.2 million, while trailing EPS moved from CHF 3.87 to CHF 4.03. This provides investors with a relatively steady view of earnings power and a margin profile that...

Kewaunee Scientific (KEQU) has just posted Q3 2026 results with revenue of US$69.4 million and basic EPS of US$0.24, alongside trailing twelve month revenue of US$287.7 million and EPS of US$3.87 that sit against a net profit margin of 4.1% versus 9.4% a year earlier. Over the past six reported quarters, revenue has ranged from US$47.8 million to US$77.1 million while quarterly EPS has moved between US$0.24 and US$1.70, giving investors a clear view of how earnings power has tracked alongside...

Verano Holdings (NEOE:VRNO) has just posted its FY 2025 numbers, with Q4 revenue of US$206.6 million and a basic EPS loss of US$0.51, alongside a trailing 12 month revenue base of US$821.5 million and a net loss of US$257.9 million. The company has seen quarterly revenue move from US$216.7 million in Q3 2024 to between about US$202 million and US$210 million across 2025, while basic EPS remained in loss making territory each quarter. For investors, the latest print keeps the focus squarely on...

Voltalia (ENXTPA:VLTSA) has reported fresh numbers for FY 2025, with first half revenue of €257.1 million and basic EPS of a €0.24 loss, while over the trailing twelve months the company recorded €588 million in revenue and a net income loss from continuing operations of €100 million. The company’s revenue moved from €238.9 million in the first half of 2024 to €297.7 million in the second half of 2024, then to €257.1 million in the first half of 2025. Over the same trailing twelve month...

If you are wondering whether Northwest Natural Holding is fairly priced or not, you are not alone. This article will help you make sense of where the current share price stands. The stock closed at US$51.94 recently, with returns of 7.5% over the last 30 days, 11.1% year to date, and 32.1% over the past year. These figures can change how investors think about both upside potential and risk. Recent moves in the share price sit alongside ongoing coverage of Northwest Natural Holding's position...

Operational outperformance and growth spending come into focus Universal Technical Institute (UTI) is back on investors’ radar after surpassing all major operational goals in fiscal 2025, even as management signaled near term profit pressure from heavy spending on new campuses and programs. See our latest analysis for Universal Technical Institute. At a share price of $35.29, Universal Technical Institute’s recent momentum is clear, with a 30.32% 1 month share price return and 42.07% year to...